|
1
|
c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571.
|
Int J Cancer
|
2003
|
0.94
|
|
2
|
Clinical significance of CXC chemokine receptor-4 and c-Met in childhood rhabdomyosarcoma.
|
Clin Cancer Res
|
2008
|
0.92
|
|
3
|
Clinical and molecular evidence for c-kit receptor as a therapeutic target in neuroblastic tumors.
|
Clin Cancer Res
|
2005
|
0.76
|
|
4
|
Detection and clinical significance of disseminated tumour cells at diagnosis in bone marrow of children with localised rhabdomyosarcoma.
|
Eur J Cancer
|
2005
|
0.76
|
|
5
|
Molecular evidence of the independent origin of multiple Wilms tumors in a case of WAGR syndrome.
|
Pediatr Blood Cancer
|
2008
|
0.75
|